Triglav Skladi’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Sell
4,000
-580
-13% -$191K 0.08% 114
2025
Q4
$1.61M Sell
4,580
-400
-8% -$135K 0.1% 101
2025
Q3
$1.61M Hold
4,980
0.11% 90
2025
Q2
$1.94M Hold
4,980
0.14% 77
2025
Q1
$2.17M Hold
4,980
0.18% 72
2024
Q4
$1.84M Buy
+4,980
New +$2.08M 0.14% 76

Other funds holding ELV

Triglav Skladi's ELV Position: Q1 2026 in Review

Triglav Skladi reduced its Elevance Health (ELV) stake by 13% in Q1 2026, selling an estimated $191K and leaving 4,000 shares worth $1.17M. The position accounts for 0.08% of the portfolio, ranked #114.

Triglav Skladi first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.17M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Triglav Skladi held 4,000 shares of Elevance Health worth $1.17M as of Q1 2026.
  • Triglav Skladi sold 580 Elevance Health shares in Q1 2026, an estimated $191K.
  • Elevance Health made up 0.08% of Triglav Skladi's portfolio in Q1 2026, its #114 holding.
  • Triglav Skladi first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • Triglav Skladi's Elevance Health position peaked at $2.17M in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Triglav Skladi's 13F filing for Q1 2026, filed 4 May 2026.